The BioScan touch i8 – IVF is the world’s first novel bedside technique
for the assessment of Intravascular (IV), Extravascular (EV) Volume,
Plasma, Blood Cells, and Hematocrit
Fluid Management
WHEN IT MATTERS
In today’s fast and busy healthcare environment clinicians are faced with important decisions, on how to prescribe correct volume of fluid. The impact of a positive fluid balance on morbidity and mortality has been well documented. Avoiding fluid overload by choosing the appropriate amount of fluids for patients who are fluid-responsive, are some of the major changes.
Whenever clinicians decide to prescribe fluids, the risks and benefits of such therapy needs to be considered in order to optimise patient outcomes. Timely information on patient fluid status is crucial for accurate diagnosis.
However, little is known about how to monitor fluid status and fluid overload. Clinicians need the ability to access and review clinically relevant patient data.
That’s where the Maltron BioScan touch i8 comes in. A non-invasive monitor which provides clinicians the ability to have access to a complete profile and the ability to obtain dynamic assessments of fluid status and changes.
The BioScan touch i8 is easy to use, it is easy to fit into your current practice. It is easy to adapt, expand and update.
BioScan touch i8 – IVF
The clear print out allows for intuitive management of data.
The 10.1” crystal clear display screen allows live viewing, clear, concise, relevant data at a glance for healthcare providers.
The dynamic View Panel interface provides color-coding and placement of vital information.